January 16, 2018
Sun Pharma will be able to sell its generic version of the constipation medication Linzess in February 2031 as part of a deal announced Tuesday to end patent infringement litigation being brought by the drug's makers, Allergan PLC and Ironwood Pharmaceuticals Inc.